+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Live Attenuated Vaccine"

Vaccines Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Thumbnail Image

Vaccines Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • July 2025
  • 210 Pages
  • Global
From
U.S. Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax, SkyZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine), By End Use, And Segment Forecasts, 2025 - 2033 - Product Thumbnail Image

U.S. Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax, SkyZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine), By End Use, And Segment Forecasts, 2025 - 2033

  • Report
  • July 2025
  • 150 Pages
  • United States
From
Asia Pacific Vaccine Market Report and Forecast 2025-2034 - Product Thumbnail Image

Asia Pacific Vaccine Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 250 Pages
  • Asia Pacific
From
Middle East Vaccines Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Thumbnail Image

Middle East Vaccines Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • October 2025
  • 99 Pages
  • Middle East
From
USA Vaccine Market outlook to 2030 - Product Thumbnail Image

USA Vaccine Market outlook to 2030

  • Report
  • June 2025
  • 90 Pages
  • United States
From
Vaccine Contract Manufacturing Market: Industry Trends and Global Forecasts to 2035: Type of Expression System Used (Mammalian, Microbial and Others), Company Size and Geographical Region - Product Thumbnail Image

Vaccine Contract Manufacturing Market: Industry Trends and Global Forecasts to 2035: Type of Expression System Used (Mammalian, Microbial and Others), Company Size and Geographical Region

  • Report
  • August 2024
  • 381 Pages
  • Global
From
Vaccine Contract Manufacturing Market Report 2023-2033 - Product Thumbnail Image

Vaccine Contract Manufacturing Market Report 2023-2033

  • Report
  • May 2023
  • 375 Pages
  • Global
From
Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by Form Type, Route of Administration, Approach, Indication, Packaging - Global Forecast to 2031 - Product Thumbnail Image

Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by Form Type, Route of Administration, Approach, Indication, Packaging - Global Forecast to 2031

  • Report
  • November 2024
  • 239 Pages
  • Global
From
Pediatric Vaccines: Global Markets - Product Thumbnail Image

Pediatric Vaccines: Global Markets

  • Report
  • September 2022
  • 110 Pages
  • Global
From
Global Markets for Vaccine Technologies - Product Thumbnail Image

Global Markets for Vaccine Technologies

  • Report
  • January 2024
  • 213 Pages
  • Global
From
Nasal Vaccines: Global Markets and Pipeline Analysis - Product Thumbnail Image

Nasal Vaccines: Global Markets and Pipeline Analysis

  • Report
  • December 2022
  • 78 Pages
  • Global
From
Pediatric Vaccines Market Size, Share & Trends Analysis Report By Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines), By Application (Cancer), By Region, And Segment Forecasts, 2024 - 2030 - Product Thumbnail Image

Pediatric Vaccines Market Size, Share & Trends Analysis Report By Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines), By Application (Cancer), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • August 2024
  • 100 Pages
  • Global
From
Seasonal Influenza Vaccine Market (2023 Edition): Analysis By Vaccine Type (Inactivated, Live Attenuated), Valency (Quadrivalent, Trivalent), Age Group, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029) - Product Thumbnail Image

Seasonal Influenza Vaccine Market (2023 Edition): Analysis By Vaccine Type (Inactivated, Live Attenuated), Valency (Quadrivalent, Trivalent), Age Group, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

  • Report
  • July 2023
  • 280 Pages
  • Global
From
Vaccine Contract Manufacturing Market - Global Outlook and Forecast 2021-2026 - Product Thumbnail Image

Vaccine Contract Manufacturing Market - Global Outlook and Forecast 2021-2026

  • Report
  • April 2021
  • 377 Pages
  • Global
From
Vaccines Global Market Opportunities And Strategies To 2031 - Product Thumbnail Image

Vaccines Global Market Opportunities And Strategies To 2031

  • Report
  • January 2023
  • 343 Pages
  • Global
From
Vaccines - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Vaccines - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 100 Pages
  • Global
From
Pediatric Vaccines Market by Vaccine Type, by Technology, by Indication, by Distribution Channel, and by Region - Product Thumbnail Image

Pediatric Vaccines Market by Vaccine Type, by Technology, by Indication, by Distribution Channel, and by Region

  • Report
  • October 2024
  • 200 Pages
  • Global
From
Anthrax Vaccine Market by Vaccine Type, by Application, by End-User, and By Region - Product Thumbnail Image

Anthrax Vaccine Market by Vaccine Type, by Application, by End-User, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Shingles Vaccine Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Shingles Vaccine Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Vaccine Contract Development And Manufacturing Organization - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Thumbnail Image

Vaccine Contract Development And Manufacturing Organization - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • July 2024
  • 120 Pages
  • Global
From
Loading Indicator

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus. Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines. Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more